Shangmei Liu
- Topics
- Virus-based gene therapy research (4 papers)Neuroendocrine Tumor Research Advances (3 papers)Lung Cancer Research Studies (3 papers)
- Partner nations
- ChinaNetherlandsAustralia
In The Last Decade
Shangmei Liu
14 papers receiving 303 citations
Peers
Comparison fields: 5 of 60
- Molecular Biology 105
- Oncology 96
- Genetics 65
- Automotive Engineering 56
- Epidemiology 55
Countries citing papers authored by Shangmei Liu
This map shows the geographic impact of Shangmei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shangmei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shangmei Liu more than expected).
Fields of papers citing papers by Shangmei Liu
This network shows the impact of papers produced by Shangmei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shangmei Liu. The network helps show where Shangmei Liu may publish in the future.
Co-authorship network of co-authors of Shangmei Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Shangmei Liu. A scholar is included among the top collaborators of Shangmei Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shangmei Liu. Shangmei Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 56 | |
| 2 | 12 | |
| 3 | 22 | |
| 4 | 10 | |
| 5 | 11 | |
| 6 | Pathologic characteristics of primary primitive neuroectodermal tumor in the cervix: a small round cell malignant tumor with glial and epithelial differentiation after neoadjuvant chemotherapy. | 1 |
| 7 | 29 | |
| 8 | 39 | |
| 9 | [Prognostic factor analysis of surgical treatment in patients with rectal neuroendocrine neoplasms]. | 1 |
| 10 | [Clinicopathological features of the primary gastric neuroendocrine neoplasms]. | 6 |
| 11 | 4 | |
| 12 | [Correlation between aneuploidy of chromosome 17, over-expression of TP53 and TOPIIalpha, and the clinicopathological features and diagnosis of gastric adenocarcinoma]. | 5 |
| 13 | 46 | |
| 14 | 64 |
About Shangmei Liu
Shangmei Liu is a scholar working on Biotechnology, Oncology and Epidemiology, having authored 14 papers that have together received 306 indexed citations. Recurring topics across this work include Virus-based gene therapy research (4 papers), Neuroendocrine Tumor Research Advances (3 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Automotive Engineering (56 citations), Oncology (96 citations) and Biotechnology (21 citations). Shangmei Liu has collaborated with scholars based in China, Netherlands and Australia. Frequent co-authors include Weixiang Shen, Haizhen Lu, Yukun Huang, Rui Xiong, Aihua Tang, Quanqing Yu, Wen Zhang, Binlei Liu, Jing Liang and Xiao‐Guang Ni. Their work appears in journals such as PLoS ONE, Scientific Reports and Applied Energy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.